Ernexa Therapeutics Inc.

ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 422 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Ernexa Therapeutics Inc., Reports and events
Filed	Form	What it is	Accession number
2019-08-0916:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-19-011993
2019-07-0809:20 ET	SC 13D/A	Ownership report, active investor, amended	0001477932-19-003932
2019-07-0806:14 ET	SC 13D/A	Ownership report, active investor, amended	0001477932-19-003930
2019-06-1016:30 ET	8-K	5.07 Shareholder vote results	0001493152-19-008932
2019-06-0517:19 ET	SC 13D/A	Ownership report, active investor, amended	0001213900-19-010117
2019-05-1416:40 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001493152-19-007099
2019-05-1316:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-19-006915
2019-04-2616:30 ET	DEF 14A	Proxy statementPeriod 2019-04-26	0001493152-19-006002
2019-03-2216:31 ET	10-K	Annual reportPeriod 2018-12-31	0001493152-19-003770
2019-03-2116:45 ET	SC 13D/A	Ownership report, active investor, amended	0001493152-19-003714
2019-03-2016:15 ET	8-K	2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001493152-19-003651
2019-01-0913:47 ET	SC 13D/A	Ownership report, active investor, amended	0001062993-19-000106
2018-12-1717:02 ET	SC 13D	Ownership report, active investor	0001213900-18-017452
2018-12-1708:30 ET	8-K	8.01 Other events	0001493152-18-017572
2018-12-0708:35 ET	8-K	5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-18-017161
2018-11-2114:13 ET	SC 13D	Ownership report, active investor	0001062993-18-004781
2018-11-0916:32 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001493152-18-015583
2018-11-0716:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-18-015345
2018-10-0108:30 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001493152-18-013929
2018-08-0616:31 ET	10-Q	Quarterly reportPeriod 2018-06-30	0001493152-18-011019
2018-08-0216:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-18-010863
2018-07-0216:30 ET	SC 13D/A	Ownership report, active investor, amended	0001493152-18-009555
2018-06-2916:15 ET	8-K	8.01 Other events	0001493152-18-009450
2018-06-2709:07 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-18-009257
2018-06-1117:20 ET	8-K	5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-18-008467
2018-05-1116:31 ET	10-Q	Quarterly reportPeriod 2018-03-31	0001493152-18-006666
2018-05-0916:10 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-18-006467
2018-04-3008:35 ET	8-K	3.01 Delisting notice; 9.01 Financial statements and exhibits	0001493152-18-005917
2018-04-2716:30 ET	DEF 14A	Proxy statementPeriod 2018-04-27	0001493152-18-005875
2018-03-2317:05 ET	8-K	3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-18-003828
2018-03-2217:00 ET	8-K	5.02 Departure or appointment of officers or directors	0001493152-18-003758
2018-03-1318:35 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001493152-18-003250
2018-03-0916:31 ET	10-K	Annual reportPeriod 2017-12-31	0001493152-18-003164
2018-03-0616:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-18-002952
2018-03-0216:15 ET	8-K	8.01 Other events	0001493152-18-002849
2018-02-0617:22 ET	SC 13D	Ownership report, active investor	0001493152-18-001558
2018-02-0508:00 ET	SC 13D	Ownership report, active investor	0001477932-18-000647
2017-12-0609:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001493152-17-014234
2017-11-3008:30 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001493152-17-013983
2017-11-0816:31 ET	10-Q	Quarterly reportPeriod 2017-09-30	0001493152-17-012607
2017-11-0716:07 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-17-012525
2017-10-2516:30 ET	8-K	5.02 Departure or appointment of officers or directors	0001493152-17-012055
2017-08-0416:16 ET	10-Q	Quarterly reportPeriod 2017-06-30	0001493152-17-008543
2017-08-0216:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-17-008398
2017-07-1008:36 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001493152-17-007627
2017-06-0916:36 ET	8-K	5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001493152-17-006434
2017-05-1507:30 ET	8-K	8.01 Other events	0001493152-17-005221
2017-05-0416:06 ET	10-Q	Quarterly reportPeriod 2017-03-31	0001493152-17-004743
2017-05-0316:10 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-17-004689
2017-04-2816:31 ET	8-K	8.01 Other events	0001493152-17-004545

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.